Literature DB >> 11036045

Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains.

A Novelli1, S Fallani, M I Cassetta, S Conti, T Mazzei.   

Abstract

The postantibiotic leukocyte enhancement (PALE) of meropenem in vitro in comparison with that of imipenem was evaluated with 24 recently isolated gram-positive and gram-negative strains. In general, pre-exposure to carbapenems (at four times the MIC for 2 h) led to increased polymorphonuclear cell phagocytic killing. The PALE of imipenem was generally significantly less than that observed with meropenem.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11036045      PMCID： PMC101625          DOI： 10.1128/AAC.44.11.3174-3176.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.

Authors:  H C Neu; A Novelli; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

2.  Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

3.  The postantibiotic effect of meropenem and imipenem on selected bacteria.

Authors:  H L Nadler; D H Pitkin; W Sheikh
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

Review 4.  Review of the in vitro spectrum of activity of imipenem.

Authors:  R N Jones
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

5.  Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics.

Authors:  A U Gerber; H P Brugger; C Feller; T Stritzko; B Stalder
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

6.  Postantibiotic effect of imipenem on Pseudomonas aeruginosa.

Authors:  C I Bustamante; G L Drusano; B A Tatem; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

7.  The in-vivo postantibiotic effect of imipenem and other new antimicrobials.

Authors:  S Gudmundsson; B Vogelman; W A Craig
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

8.  Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes.

Authors:  P J McDonald; B L Wetherall; H Pruul
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

9.  Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes.

Authors:  S Yan; G A Bohach; D L Stevens
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

Review 10.  The carbapenems: new broad spectrum beta-lactam antibiotics.

Authors:  R C Moellering; G M Eliopoulos; D E Sentochnik
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790
View more
  5 in total

1.  Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.

Authors:  Sarah Fawaz; Stephen Barton; Laura Whitney; Julian Swinden; Shereen Nabhani-Gebara
Journal:  Hosp Pharm       Date:  2018-05-30

2.  Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.

Authors:  Jessica A O'Hara; Lauretta A Ambe; Leila G Casella; Bethany M Townsend; Mark R Pelletier; Robert K Ernst; Robert M Q Shanks; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

3.  Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria.

Authors:  Amol T Kothekar; Jigeeshu Vasishtha Divatia; Sheila Nainan Myatra; Anand Patil; Manjunath Nookala Krishnamurthy; Harish Mallapura Maheshwarappa; Suhail Sarwar Siddiqui; Murari Gurjar; Sanjay Biswas; Vikram Gota
Journal:  Ann Intensive Care       Date:  2020-01-10       Impact factor: 6.925

4.  Continuous infusion of meropenem in critically ill patients: practical considerations.

Authors:  Fabio Silvio Taccone
Journal:  Crit Care       Date:  2012-08-27       Impact factor: 9.097

Review 5.  Antibiotics and ECMO in the Adult Population-Persistent Challenges and Practical Guides.

Authors:  Francisco Gomez; Jesyree Veita; Krzysztof Laudanski
Journal:  Antibiotics (Basel)       Date:  2022-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.